The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

Viatris shares favorable Phase 3 data for contraceptive patch and pain drug, affirms 2025 sales, and raises adjusted EPS ...

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical ...

Rai: The empirical data support legislative reform that would lift the automatic 30-month stay of a generic’s approval by the ...

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

Another item many of us buy prescription drugs. President Trump said this week ... “Assuming the current global tariff rates, ...

THE new Food and Drug Administration (FDA) application procedures are expected to reduce the drug permit process by as much ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Qure advances its Huntington’s program toward accelerated approval as PTC Therapeutics reports strong Phase 2 results. Learn ...

The product, available in 200 mg, 400 mg, 600 mg, and 800 mg strengths, is the generic equivalent of Sumitomo Pharma ...